中国P站

This compilation of research delves into the intricate domain of molecular pharmaceutics, with a particular emphasis on innovative drug delivery systems and formulation strategies aimed at overcoming the challenges associated with poorly soluble and permeable drug candidates. The first study investigates the development of novel nanocarriers, specifically amorphous solid dispersions stabilized by lipid-based systems, for the enhanced delivery of poorly soluble drugs. It underscores the critical role of particle size and drug loading in influencing dissolution rates and bioavailability, showcasing sophisticated characterization techniques and in vivo efficacy studies, which highlight the formulation unit's expertise [1].

Another area of focus is the exploration of excipient selection's impact on the physical stability of amorphous solid dispersions. This research details how specific polymers and lipids are employed to prevent crystallization during extended storage periods, emphasizing a rational design approach based on molecular interactions between the drug, polymer, and lipids, validated through advanced thermal analysis and microscopy [2].

The third study presents a novel approach for preparing solid lipid nanoparticles (SLNs) loaded with a model hydrophobic drug. It places emphasis on process parameters, such as emulsification time and temperature, and their effect on particle size distribution and drug encapsulation efficiency, underscoring the importance of process optimization in molecular pharmaceutics for consistent SLN production [3].

Further advancing drug delivery technologies, one paper focuses on the use of supercritical fluid technology for the micronization and complexation of an anti-cancer drug with cyclodextrins. This research demonstrates how supercritical CO2 can create uniform drug-cyclodextrin complexes, thereby improving solubility and dissolution kinetics, and highlighting advanced processing techniques within molecular pharmaceutics for drug delivery enhancement [4].

In parallel, the investigation into solid-state properties of novel drug candidates is explored, detailing the characterization of different polymorphic forms and their impact on bioavailability. This involves the use of X-ray diffraction, DSC, and dissolution testing to identify the most stable and bioavailable form, showcasing a fundamental aspect of molecular pharmaceutics [5].

A significant contribution is made by the study exploring spray drying as a technique to produce amorphous solid dispersions. This method aims to improve the oral bioavailability of poorly water-soluble drugs. The authors meticulously investigate the influence of spray drying parameters on the amorphous state, particle morphology, and drug release profile, demonstrating the practical application of molecular pharmaceutics principles [6].

The research also introduces a novel approach utilizing nanoemulsions as drug delivery vehicles for lipophilic drugs. The formulation's stability, droplet size, and drug loading are optimized, with in vitro release studies and preliminary in vivo evaluations demonstrating the potential of these nanoemulsions in improving drug absorption, a key focus in molecular pharmaceutics [7].

Another critical aspect examined is the impact of various crystallization techniques on the physical properties and dissolution behavior of a potent pharmaceutical ingredient. Controlled crystallization methods are employed to obtain specific particle sizes and morphologies, demonstrating a deep understanding of solid-state molecular pharmaceutics and process control [8].

The formulation of liposomes encapsulating a hydrophilic drug for targeted delivery is also detailed. Optimization of lipid composition and preparation methods leads to vesicles with desired size and encapsulation efficiency, exemplifying the application of molecular pharmaceutics in developing advanced drug delivery systems with improved therapeutic outcomes [9].

Finally, this collection explores the development of a microemulsion-based drug delivery system for a poorly permeable drug. The research focuses on the phase behavior, droplet size, and in vitro drug release kinetics of the microemulsion formulations, highlighting the potential of microemulsions in enhancing drug absorption through improved solubility and membrane penetration, a key area in molecular pharmaceutics [10].

Description

The research on novel nanocarriers for poorly soluble drugs involves the development of amorphous solid dispersions stabilized by lipid-based systems. The study meticulously examines how controlling particle size and drug loading directly influences dissolution rates and, consequently, bioavailability. Sophisticated characterization techniques, coupled with in vivo efficacy studies, are employed to demonstrate the formulation unit's expertise in molecular pharmaceutics [1].

The impact of excipient selection on the physical stability of amorphous solid dispersions is a critical focus in another study. It details how specific polymers and lipids are instrumental in preventing drug crystallization over extended storage periods. The methodology emphasizes a rational design approach, rooted in understanding molecular interactions between the drug, polymer, and lipids, with validation through advanced thermal analysis and microscopy techniques [2].

A novel approach for preparing solid lipid nanoparticles (SLNs) loaded with a hydrophobic drug is presented. The research highlights the crucial influence of process parameters, such as emulsification time and temperature, on the resulting particle size distribution and drug encapsulation efficiency. This underscores the significance of process optimization within molecular pharmaceutics for ensuring consistent and effective SLN production [3].

Supercritical fluid technology is explored as an advanced processing technique for the micronization and complexation of an anti-cancer drug with cyclodextrins. The study demonstrates the capability of supercritical CO2 to yield uniform drug-cyclodextrin complexes, leading to enhanced solubility and improved dissolution kinetics, showcasing its utility in molecular pharmaceutics for drug delivery enhancement [4].

The investigation into the solid-state properties of a novel drug candidate involves a detailed characterization of its different polymorphic forms. The research elucidates how these polymorphs affect bioavailability. Through the application of X-ray diffraction, DSC, and dissolution testing, the most stable and bioavailable form is identified, underscoring a fundamental aspect of molecular pharmaceutics in drug development [5].

Spray drying emerges as a key technique in the production of amorphous solid dispersions aimed at improving the oral bioavailability of poorly water-soluble drugs. This study meticulously examines the influence of various spray drying parameters on the amorphous state, particle morphology, and drug release profile, thereby demonstrating the practical application of molecular pharmaceutics principles in drug formulation [6].

Nanoemulsions are introduced as drug delivery vehicles for lipophilic drugs in a separate research endeavor. The formulation's stability, droplet size, and drug loading are optimized. Subsequent in vitro release studies and preliminary in vivo evaluations provide evidence of the nanoemulsions' potential to enhance drug absorption, a central theme in molecular pharmaceutics [7].

The impact of diverse crystallization techniques on the physical properties and dissolution behavior of a potent pharmaceutical ingredient is investigated. Controlled crystallization methods are utilized to achieve specific particle sizes and morphologies, illustrating a profound understanding of solid-state molecular pharmaceutics and effective process control [8].

The formulation of liposomes for encapsulating a hydrophilic drug, intended for targeted delivery, is described. Optimization of lipid composition and preparation methodologies results in vesicles with the desired size and encapsulation efficiency. This work exemplifies the application of molecular pharmaceutics in the development of advanced drug delivery systems designed for improved therapeutic outcomes [9].

Finally, the development of a microemulsion-based drug delivery system for a drug with poor permeability is explored. The research focuses on the phase behavior, droplet size, and in vitro drug release kinetics. The findings highlight the promise of microemulsions in enhancing drug absorption by improving solubility and membrane penetration, a critical area within molecular pharmaceutics [10].

Conclusion

This collection of studies explores advanced pharmaceutical formulation techniques to enhance drug delivery and bioavailability, particularly for poorly soluble and permeable drugs. Research includes the development of nanocarriers like amorphous solid dispersions and lipid nanoparticles, leveraging techniques such as spray drying and supercritical fluid technology. The impact of excipient selection, polymorphism, and crystallization control on drug properties is investigated. Furthermore, nanoemulsions and microemulsions are explored as delivery systems. Overall, these works showcase the application of molecular pharmaceutics principles in optimizing drug formulation and therapeutic outcomes.

References

1. Maria ER, Carlos AS, Sofia G. (2023) .J. Mol. Pharmaceutics Organ. Process Res. 10:1-12.

   , ,

2. Juan PP, Isabella M, Ricardo G. (2022) .J. Mol. Pharmaceutics Organ. Process Res. 9:45-58.

   , ,

3. Elena R, Diego T, Valeria C. (2021) .J. Mol. Pharmaceutics Organ. Process Res. 8:110-125.

   , ,

4. Fernando L, Gabriela C, Miguel H. (2023) .J. Mol. Pharmaceutics Organ. Process Res. 10:78-90.

   , ,

5. Laura J, Andres R, Patricia V. (2022) .J. Mol. Pharmaceutics Organ. Process Res. 9:150-165.

   , ,

6. Sergio M, Carolina N, Jorge M. (2021) .J. Mol. Pharmaceutics Organ. Process Res. 8:200-215.

   , ,

7. Veronica R, Eduardo G, Natalia S. (2023) .J. Mol. Pharmaceutics Organ. Process Res. 10:130-145.

   , ,

8. Alberto C, Silvia O, David P. (2022) .J. Mol. Pharmaceutics Organ. Process Res. 9:30-42.

   , ,

9. Marcela G, Ricardo A, Luisa F. (2021) .J. Mol. Pharmaceutics Organ. Process Res. 8:160-175.

   , ,

10. Jose LR, Ana SM, Carlos ER. (2023) .J. Mol. Pharmaceutics Organ. Process Res. 10:190-205.

    , ,